BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $977 | -22.2% | 25,280 | -24.0% | 0.08% | -28.6% |
Q3 2023 | $1,256 | -17.2% | 33,276 | -0.0% | 0.11% | -13.8% |
Q2 2023 | $1,516 | +12.3% | 33,280 | 0.0% | 0.13% | +6.6% |
Q1 2023 | $1,350 | -20.4% | 33,280 | 0.0% | 0.12% | -23.3% |
Q4 2022 | $1,696 | -99.9% | 33,280 | 0.0% | 0.16% | -9.7% |
Q3 2022 | $1,793,000 | -16.1% | 33,280 | 0.0% | 0.18% | -7.9% |
Q2 2022 | $2,138,000 | -18.2% | 33,280 | 0.0% | 0.19% | -1.5% |
Q1 2022 | $2,615,000 | -8.5% | 33,280 | 0.0% | 0.19% | -4.0% |
Q4 2021 | $2,857,000 | +6.7% | 33,280 | 0.0% | 0.20% | -2.9% |
Q3 2021 | $2,677,000 | -0.1% | 33,280 | 0.0% | 0.21% | +1.0% |
Q2 2021 | $2,679,000 | -4.6% | 33,280 | 0.0% | 0.21% | -11.6% |
Q1 2021 | $2,807,000 | +5.1% | 33,280 | 0.0% | 0.23% | +0.9% |
Q4 2020 | $2,670,000 | -0.2% | 33,280 | 0.0% | 0.23% | -8.7% |
Q3 2020 | $2,676,000 | -6.6% | 33,280 | 0.0% | 0.25% | -14.5% |
Q2 2020 | $2,865,000 | -47.9% | 33,280 | -50.1% | 0.30% | -1.0% |
Q1 2020 | $5,501,000 | +96.5% | 66,753 | +99.4% | 0.30% | +8.7% |
Q4 2019 | $2,799,000 | -4.4% | 33,473 | 0.0% | 0.28% | -11.3% |
Q3 2019 | $2,928,000 | +6.8% | 33,473 | 0.0% | 0.31% | +6.9% |
Q2 2019 | $2,742,000 | +0.6% | 33,473 | -0.1% | 0.29% | +0.3% |
Q1 2019 | $2,726,000 | +23.6% | 33,523 | 0.0% | 0.29% | +7.8% |
Q4 2018 | $2,206,000 | -14.6% | 33,523 | 0.0% | 0.27% | +5.1% |
Q3 2018 | $2,584,000 | +2.8% | 33,523 | -1.5% | 0.26% | -3.8% |
Q2 2018 | $2,514,000 | +13.5% | 34,050 | 0.0% | 0.26% | +8.6% |
Q1 2018 | $2,215,000 | +0.6% | 34,050 | 0.0% | 0.24% | +5.2% |
Q4 2017 | $2,201,000 | +3.0% | 34,050 | 0.0% | 0.23% | -2.5% |
Q3 2017 | $2,137,000 | +3.7% | 34,050 | 0.0% | 0.24% | +1.3% |
Q2 2017 | $2,061,000 | +16.7% | 34,050 | 0.0% | 0.24% | +16.3% |
Q1 2017 | $1,766,000 | +17.0% | 34,050 | 0.0% | 0.20% | +13.5% |
Q4 2016 | $1,510,000 | -6.8% | 34,050 | 0.0% | 0.18% | -6.8% |
Q3 2016 | $1,621,000 | +5.1% | 34,050 | -0.1% | 0.19% | +3.2% |
Q2 2016 | $1,542,000 | +10.1% | 34,100 | 0.0% | 0.18% | +8.8% |
Q1 2016 | $1,401,000 | +7.8% | 34,100 | 0.0% | 0.17% | +9.0% |
Q4 2015 | $1,300,000 | +16.1% | 34,100 | 0.0% | 0.16% | +13.9% |
Q3 2015 | $1,120,000 | -53.0% | 34,100 | 0.0% | 0.14% | -47.5% |
Q2 2015 | $2,384,000 | +2.1% | 34,100 | 0.0% | 0.26% | +7.4% |
Q1 2015 | $2,336,000 | -6.7% | 34,100 | -0.2% | 0.24% | -4.0% |
Q4 2014 | $2,504,000 | +2.1% | 34,159 | 0.0% | 0.25% | +4.5% |
Q3 2014 | $2,452,000 | +234.1% | 34,159 | +236.2% | 0.24% | +227.0% |
Q2 2014 | $734,000 | -1.2% | 10,159 | +0.6% | 0.07% | -7.5% |
Q1 2014 | $743,000 | -12.0% | 10,100 | -16.7% | 0.08% | -12.1% |
Q4 2013 | $844,000 | -36.8% | 12,125 | -40.3% | 0.09% | -41.7% |
Q3 2013 | $1,335,000 | – | 20,325 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |